Matthew Frieman

Cytowane przez

	Wszystkie	Od 2020
Cytowania	23311	18787
h-indeks	77	67
i10-indeks	129	120

6000

3000

1500

4500

2006200720082009201020112012201320142015201620172018201920202021202220232024202568 137 176 192 196 186 239 304 414 500 527 444 410 475 3407 5439 4388 2952 2128 346

Dostęp publiczny

Wyświetl wszystko

134 artykuły

3 artykuły

dostępne

niedostępne

Objęte finansowaniem

Współautorzy

Christopher ColemanUniversity of NottinghamZweryfikowany adres z exmail.nottingham.ac.uk
Jimmy LogueMapp Biopharmaceutical, Inc.Zweryfikowany adres z logues.net
Lisa E HensleyResearch Lead Zoonotic and emerging disease research unitZweryfikowany adres z usda.gov
Mark T. HeiseThe University of North CarolinaZweryfikowany adres z med.unc.edu
Thiagarajan VenkataramanResearch Associate, University of Maryland School of MedicineZweryfikowany adres z som.umaryland.edu
Gene Garrard Olinger Jr.Adjunct Professor Medicine, Boston UniversityZweryfikowany adres z bu.edu
Jason KindrachukUniversity of ManitobaZweryfikowany adres z umanitoba.ca
Louis TaylorUniversity of Maryland School of MedicineZweryfikowany adres z upenn.edu
Mohammad M SajadiInstitute of Human Virology at the University of Maryland School of MedicineZweryfikowany adres z ihv.umaryland.edu
Donald Ingber, MD,PhDHarvard U. Professor and Director, Wyss InstituteZweryfikowany adres z wyss.harvard.edu
Susan R WeissUniversity of PennsylvaniaZweryfikowany adres z pennmedicine.upenn.edu
Timothy SheahanUniversity of North Carolina at Chapel HillZweryfikowany adres z email.unc.edu
Jens H. KuhnNIH/NIAID/DCR/Integrated Research Facility at Fort Detrick (IRF-Frederick)Zweryfikowany adres z mail.nih.gov
Kanta SubbaraoDirector, WHO Collaborating Centre for Reference and Research on InfluenzaZweryfikowany adres z influenzacentre.org
Thomas E. "Tem" MorrisonProfessor of Immunology and Microbiology, University of Colorado School of MedicineZweryfikowany adres z cuanschutz.edu
Martin T. FerrisAssociate Professor, Department of Genetics, University of North Carolina at Chapel HillZweryfikowany adres z email.unc.edu
Lisa E. GralinskiDepartment of Epidemiology, University of North CarolinaZweryfikowany adres z email.unc.edu
Xue YongFDA/CDRHZweryfikowany adres z fda.hhs.gov
Donald K Milton, MD, DrPHProfessor of Environmental & Occupational Health University of MarylandZweryfikowany adres z umd.edu
Sheldon TaiUniversity of MarylandZweryfikowany adres z umd.edu

Obserwuj

Matthew Frieman

Professor, University of Maryland School of Medicine

Zweryfikowany adres z som.umaryland.edu - Strona główna

virology Coronavirus viral pathogenesis therapeutics


Tytuł Sortuj wg cytatów Sortuj wg roku Sortuj wg tytułu	Cytowane przez Cytowane przez	Rok
Phase 1–2 trial of a SARS-CoV-2 recombinant spike protein nanoparticle vaccine C Keech, G Albert, I Cho, A Robertson, P Reed, S Neal, JS Plested, M Zhu, ... New england journal of medicine 383 (24), 2320-2332, 2020	1354	2020
Studies in humanized mice and convalescent humans yield a SARS-CoV-2 antibody cocktail J Hansen, A Baum, KE Pascal, V Russo, S Giordano, E Wloga, BO Fulton, ... Science 369 (6506), 1010-1014, 2020	1061	2020
Animal models for COVID-19 C Muñoz-Fontela, WE Dowling, SGP Funnell, PS Gsell, AX Riveros-Balta, ... Nature 586 (7830), 509-515, 2020	882	2020
Severe acute respiratory syndrome coronavirus open reading frame (ORF) 3b, ORF 6, and nucleocapsid proteins function as interferon antagonists SA Kopecky-Bromberg, L Martínez-Sobrido, M Frieman, RA Baric, ... Journal of virology 81 (2), 548-557, 2007	789	2007
Selective naked-eye detection of SARS-CoV-2 mediated by N gene targeted antisense oligonucleotide capped plasmonic nanoparticles P Moitra, M Alafeef, K Dighe, MB Frieman, D Pan ACS nano 14 (6), 7617-7627, 2020	787	2020
Repurposing of clinically developed drugs for treatment of Middle East respiratory syndrome coronavirus infection J Dyall, CM Coleman, BJ Hart, T Venkataraman, MR Holbrook, ... Antimicrobial agents and chemotherapy 58 (8), 4885-4893, 2014	751	2014
Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms DE Gordon, J Hiatt, M Bouhaddou, VV Rezelj, S Ulferts, H Braberg, ... Science 370 (6521), eabe9403, 2020	697	2020
Bats and coronaviruses A Banerjee, K Kulcsar, V Misra, M Frieman, K Mossman Viruses 11 (1), 41, 2019	625	2019
Severe acute respiratory syndrome coronavirus ORF6 antagonizes STAT1 function by sequestering nuclear import factors on the rough endoplasmic reticulum/Golgi membrane M Frieman, B Yount, M Heise, SA Kopecky-Bromberg, P Palese, RS Baric Journal of virology 81 (18), 9812-9824, 2007	624	2007
SARS-CoV-2 spike glycoprotein vaccine candidate NVX-CoV2373 immunogenicity in baboons and protection in mice JH Tian, N Patel, R Haupt, H Zhou, S Weston, H Hammond, J Logue, ... Nature communications 12 (1), 372, 2021	456	2021
Antiviral potential of ERK/MAPK and PI3K/AKT/mTOR signaling modulation for Middle East respiratory syndrome coronavirus infection as identified by temporal kinome analysis J Kindrachuk, B Ork, BJ Hart, S Mazur, MR Holbrook, MB Frieman, ... Antimicrobial agents and chemotherapy 59 (2), 1088-1099, 2015	424	2015
Severe acute respiratory syndrome coronavirus papain-like protease ubiquitin-like domain and catalytic domain regulate antagonism of IRF3 and NF-κB signaling M Frieman, K Ratia, RE Johnston, AD Mesecar, RS Baric Journal of virology 83 (13), 6689-6705, 2009	422	2009
Comorbid diabetes results in immune dysregulation and enhanced disease severity following MERS-CoV infection KA Kulcsar, CM Coleman, SE Beck, MB Frieman JCI insight 4 (20), e131774, 2019	421	2019
Severe acute respiratory syndrome coronavirus evades antiviral signaling: role of nsp1 and rational design of an attenuated strain MG Wathelet, M Orr, MB Frieman, RS Baric Journal of virology 81 (21), 11620-11633, 2007	398	2007
Binding and neutralization antibody titers after a single vaccine dose in health care workers previously infected with SARS-CoV-2 S Saadat, ZR Tehrani, J Logue, M Newman, MB Frieman, AD Harris, ... Jama 325 (14), 1467-1469, 2021	387	2021
Evidence supporting a zoonotic origin of human coronavirus strain NL63 J Huynh, S Li, B Yount, A Smith, L Sturges, JC Olsen, J Nagel, ... Journal of virology 86 (23), 12816-12825, 2012	386	2012
A human-airway-on-a-chip for the rapid identification of candidate antiviral therapeutics and prophylactics L Si, H Bai, M Rodas, W Cao, CY Oh, A Jiang, R Moller, D Hoagland, ... Nature biomedical engineering 5 (8), 815-829, 2021	359	2021
Insights from nanomedicine into chloroquine efficacy against COVID-19 TY Hu, M Frieman, J Wolfram Nature nanotechnology 15 (4), 247-249, 2020	346	2020
Purified coronavirus spike protein nanoparticles induce coronavirus neutralizing antibodies in mice CM Coleman, YV Liu, H Mu, JK Taylor, M Massare, DC Flyer, GM Glenn, ... Vaccine 32 (26), 3169-3174, 2014	346	2014
Severe acute respiratory syndrome coronavirus group-specific open reading frames encode nonessential functions for replication in cell cultures and mice B Yount, RS Roberts, AC Sims, D Deming, MB Frieman, J Sparks, ... Journal of virology 79 (23), 14909-14922, 2005	320	2005

Nie można teraz wykonać tej operacji. Spróbuj ponownie później.

Prace 1–20

Cytowania rocznie

Powielone cytowania

Scalone cytowania

Dodaj współautorówWspółautorzy

Obserwuj

Cytowane przez

Współautorzy